Companies around the world are working on better ways to manage diabetes. Universities and other research institutions are working on finding a cure for diabetes and its complications. We provide an outlet for press releases from these organizations, so that you can better understand what they're working on.
Press Releases from 2017
14 June 2017
- Insulet Presents Positive Omnipod® Horizon™ Hybrid Closed-Loop Study Results in Children.
- Tandem Diabetes Care Presents Findings from Predictive Low Glucose Suspend (PLGS) Feasibility Study and Announces Approval of Investigational Device Exemption (IDE) for Pivotal Trial.
- DexCom Announces FDA Approval of G5 Mobile App for Android Devices.
- Roche Diabetes Care Introduces Blood Glucose Meter and Savings Program Designed to Help the Over 29 Million People Living with Diabetes.
- Leading Health Organizations Announce Launch of Alliance for Transparent & Affordable Prescriptions.
7 June 2017
- Beyond Type 1's Cross Country "Bike Beyond" Program To Kick Off On June 3rd, 2017.
24 May 2017
- JDRF and ViaCyte Announce Support for Development of PEC-Direct Cell Replacement Therapy for Type 1 Diabetes.
17 May 2017
- The College Diabetes Network and JDRF Announce National Partnership.
- Livongo Partners with American Diabetes Association, Beyond Type 1, Diabetes Hands Foundation, and JDRF on New Direct-to-Consumer Diabetes Management Program.
10 May 2017
- Cross-Industry Partnership Reduces The Cost Of Popular Diabetes, Asthma And Other Brand Name Drugs.
3 May 2017
- TetraGenetics Receives Investment from JDRF T1D Fund. See also JDRF T1D Fund Invests in TetraGenetics.
19 April 2017
- Rates of new diagnosed cases of type 1 and type 2 diabetes on the rise among children, teens.
- FDA Approves New Treatment Option for People with Diabetic Retinopathy.
- GeNeuro Initiates Phase 2a Study with GNbAC1 in Type 1 Diabetes in Australia.
12 April 2017
- Life with Type 1 Diabetes Made a Little Easier through Lilly Diabetes Scholarship Donations for Camps, College and Conferences.
- Tandem Diabetes Care Launches New t:connect Diabetes Management Application Portal for Healthcare Providers.
- Government of Canada and JDRF join forces to defeat diabetes.
29 March 2017
- Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy.
- DCU Researchers make significant diabetes finding with 3U Diabetes Consortium.
22 March 2017
- Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes.
- New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials.
15 March 2017
- Tandem Diabetes Care Launches First Ever Remote Software Update for Insulin Pump using a Personal Computer.
1 March 2017
- Beyond Type 1 Provides Grant to ViaCyte to Support Research and Development of Cell Replacement Therapies for T1D.
22 February 2017
- Insulet Presents Strong Omnipod® Horizon™ Hybrid Closed-Loop Study Results at ATTD in Paris.
15 February 2017
- American Diabetes Association® Launches Online Hub for Insulin Affordability Advocates.
- Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump (SAP) over Medtronic MiniMed SAPs.
- T1D Exchange Investment -- Bigfoot Biomedical.
- American Diabetes Association Announces $9.75 million to Six Leading Researchers for the 2017 Pathway to Stop Diabetes Research Grants.
8 February 2017
- Four pivotal NIH-funded artificial pancreas research efforts begin.
- Industry Leaders Ascensia Diabetes Care And Glooko Announce Diabetes Technology Partnership To Deliver Integrated Diabetes Data Solutions.
1 February 2017
- JDRF Expresses Profound Loss at the Passing of Actress Mary Tyler Moore, Longtime Champion of the Community Living with Type 1 Diabetes.
- JDRF Launches Early-Stage Investment Fund to Catalyze Development of Commercial Type 1 Diabetes Therapies.
18 January 2017
- City of Hope sets new goal for type 1 diabetes cure. See also The Wanek Family Project to Cure Type 1 Diabetes.
- Lexicon Reports Positive Top-line Results In Second Pivotal Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes.
To have your press release included on this page, please use our Feedback Form. Please be sure to include contact information in case we have questions. We reserve the right to include only those press releases that are consistent with our editorial positions.
Last Updated: Wednesday June 21, 2017 18:44:29
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2017. Comments and Feedback.